Scribe Therapeutics, Inc. [SCTX] - IPO

Scribe Therapeutics, Inc. priced its initial public offering at $15.00 per share, raising total gross proceeds of approximately $128.7 million before expenses, with underwriters granted a 30-day option to purchase up to 1,287,000 additional shares.

View source filing ↗